Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
about
Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled CompoundsConcentrations of oral lomefloxacin in serum and bronchial mucosa.Pulmonary disposition of antimicrobial agents: methodological considerations.Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevanceDelivering antibacterials to the lungs: considerations for optimizing outcomes.Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patientsPenetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.Effect of macrolide antibiotics on macrophage functions.Antibiotic penetration into lung tissues.Genitourinary chlamydial infection: a reappraisal and hypothesis.Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid.Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.High-Performance Liquid Chromatographic Determination of Roxithromycin in Tablets
P2860
Q26738341-B10D8282-1A35-4233-B0AE-EE2AC1705B22Q35258597-C2E39788-8C39-49CD-8F06-0C3925862FC1Q35447413-1CD3D8AD-7CD9-4986-A1AF-35A88B4CF1DFQ35447443-8364C5B9-8CA5-4CE2-8D80-3F7FD2893027Q35627814-611BE0C6-C4F0-43BF-961B-1F932B5F4ADEQ35808723-7D6724BE-BBBC-4A22-BB8D-7AD217264343Q36757699-71C5F4B2-23ED-4F54-A031-6B103DBA6ADDQ37927017-F26479B9-9E26-49FA-8DE4-2B81CAAEDE69Q41247296-DA6D4D44-CBE6-4503-86EB-C0226B71A307Q42417997-49290BC0-E99B-43BB-8510-24782C08EA7AQ43427569-FE0B8417-2534-4032-AC6C-8AB6CBA946B7Q43755813-DF190E28-FAB6-4636-84A5-23DA2272AC09Q44540492-2D388288-AC41-4D3E-A345-FF0DBA4F2D51Q44869380-5878FC0B-4BDE-40A7-80FD-DF3660A4EC7EQ58309093-2E14AFDD-3B4A-4239-8297-621D92F7E8B6
P2860
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@ast
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@en
type
label
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@ast
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@en
prefLabel
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@ast
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@en
P2093
P2860
P356
P1476
Pulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.
@en
P2093
Fourtillan JB
Trouillet JL
P2860
P304
P356
10.1128/AAC.31.9.1312
P407
P577
1987-09-01T00:00:00Z